Nanotechnology Now – Press Release: Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results

Residence > Press > Arrowhead Prescription drugs to Webcast Fiscal 2021 Second Quarter Outcomes

Summary:
Arrowhead Prescription drugs Inc. (NASDAQ: ARWR) as we speak introduced that it’s going to host a webcast and convention name on Might four, 2021, at four:30 p.m. ET to debate its monetary outcomes for the fiscal second quarter ended March 31, 2021.

Arrowhead Prescription drugs to Webcast Fiscal 2021 Second Quarter Outcomes


Pasadena. CA | Posted on April 16th, 2021

Convention Name and Webcast Particulars

Buyers might entry a reside audio webcast on the Firm’s web site at http://ir.arrowheadpharma.com/occasions.cfm . For analysts that want to take part within the convention name, please dial 855-215-6159 or 315-625-6887 and supply Convention ID 3080187.

A replay of the webcast can be accessible on the corporate’s web site roughly two hours after the conclusion of the decision and can stay accessible for 90 days. An audio replay may even be accessible roughly two hours after the conclusion of the decision and can be accessible for three days. To entry the audio replay, dial 855-859-2056 or 404-537-3406 and supply Convention ID 3080187.

####

About Arrowhead Prescription drugs, Inc.
Arrowhead Prescription drugs develops medicines that deal with intractable ailments by silencing the genes that trigger them. Utilizing a broad portfolio of RNA chemistries and environment friendly modes of supply, Arrowhead therapies set off the RNA interference mechanism to induce speedy, deep, and sturdy knockdown of goal genes. RNA interference, or RNAi, is a mechanism current in residing cells that inhibits the expression of a particular gene, thereby affecting the manufacturing of a particular protein. Arrowhead’s RNAi-based therapeutics leverage this pure pathway of gene silencing.

For extra data, please go to www.arrowheadpharma.com, or comply with us on Twitter @ArrowheadPharma. To be added to the Firm’s electronic mail checklist and obtain information immediately, please go to http://ir.arrowheadpharma.com/email-alerts .

Secure Harbor Assertion underneath the Non-public Securities Litigation Reform Act:

This information launch accommodates forward-looking statements inside the which means of the “secure harbor” provisions of the Non-public Securities Litigation Reform Act of 1995. Any statements contained on this launch apart from historic data could also be deemed to be forward-looking statements. With out limiting the generality of the foregoing, phrases corresponding to “might,” “will,” “anticipate,” “consider,” “anticipate,” “intend,” “plan,” “venture,” “may,” “estimate,” or “proceed” are meant to establish such forward-looking statements. As well as, any statements that consult with projections of our future monetary efficiency, traits in our companies, or different characterizations of future occasions or circumstances are forward-looking statements. These statements are primarily based upon our present expectations and communicate solely as of the date hereof. Our precise outcomes might differ materially and adversely from these expressed in any forward-looking statements because of quite a few components and uncertainties, together with the persevering with affect of the COVID-19 pandemic, the security and efficacy of our product candidates, the length and affect of regulatory delays in our scientific packages, our skill to finance our operations, the probability and timing of the receipt of future milestone and licensing charges, the longer term success of our scientific research, our skill to efficiently develop and commercialize drug candidates, the timing for beginning and finishing scientific trials, speedy technological change in our markets, the enforcement of our mental property rights, and the opposite dangers and uncertainties described in our most up-to-date Annual Report on Kind 10-Okay, subsequent Quarterly Reviews on Kind 10-Q and different paperwork filed with the Securities and Trade Fee once in a while. We assume no obligation to replace or revise forward-looking statements to replicate new occasions or circumstances.

For extra data, please click on right here

Contacts:
Arrowhead Prescription drugs, Inc.
Vince Anzalone, CFA
626-304-3400

Buyers:
LifeSci Advisors, LLC
Brian Ritchie
212-915-2578

www.lifesciadvisors.com

Media:
LifeSci Communications, LLC
Josephine Belluardo, Ph.D.
646-751-4361

www.lifescicommunications.com

Copyright © Arrowhead Prescription drugs, Inc.

If in case you have a remark, please Contact us.

Issuers of reports releases, not seventh Wave, Inc. or Nanotechnology Now, are solely answerable for the accuracy of the content material.

Bookmark:
Delicious
Digg
Newsvine
Google
Yahoo
Reddit
Magnoliacom
Furl
Facebook

Information and data


Wearable sensors that detect fuel leaks April 19th, 2021


JEOL USA Welcomes New Managing Director, Hidetaka Sawada April 19th, 2021


FSU engineers enhance efficiency of high-temperature superconductor wires April 16th, 2021


Arrowhead Prescription drugs to Webcast Fiscal 2021 Second Quarter Outcomes April 16th, 2021

Nanomedicine


Arrowhead Prescription drugs to Webcast Fiscal 2021 Second Quarter Outcomes April 16th, 2021


French & Swiss Scientists Reveal ‘All-in-One’ Approach that May Speed up Phage-Remedy Prognosis: Lensless Imaging System Affirms Phage Remedy’s Worth in Treating Severe An infection, Tracks Phage Resistance and May Simply Be Applied in Compact Gadgets at Phage Lab April 13th, 2021


Antibody binding-site conserved throughout COVID-19 virus variants: The structural revelation may have implications as a therapeutic goal in all SARS-CoV-2 variants April ninth, 2021


Discovery may assist lengthen lifespan of digital units: The analysis may result in electronics being designed with higher endurance April ninth, 2021

Bulletins


Wearable sensors that detect fuel leaks April 19th, 2021


JEOL USA Welcomes New Managing Director, Hidetaka Sawada April 19th, 2021


FSU engineers enhance efficiency of high-temperature superconductor wires April 16th, 2021


Arrowhead Prescription drugs to Webcast Fiscal 2021 Second Quarter Outcomes April 16th, 2021

Monetary Reviews


Arrowhead Prescription drugs to Webcast Fiscal 2021 Second Quarter Outcomes April 16th, 2021


180 Diploma Capital Corp. Reviews +6.7% Development in This autumn 2020, $9.28 Internet Asset Worth per Share as of December 31, 2020, and Developments from Q1 2021 Together with Anticipated Funding in a Deliberate SPAC Sponsor February 22nd, 2021


180 Diploma Capital Corp. to Report Fourth Quarter 2020 Monetary Outcomes on Monday, February 22, 2021 and to Host a Convention Name on Tuesday, February 23, 2021 February 19th, 2021


Arrowhead Prescription drugs to Webcast Fiscal 2021 First Quarter Outcomes January 20th, 2021

Occasions/Courses


Arrowhead Prescription drugs to Webcast Fiscal 2021 Second Quarter Outcomes April 16th, 2021


CEA-Leti Envisions Widespread Use of LiDAR Programs Based mostly on Built-in Optical Phased Arrays (OPAs): OPAs with Stable-State Beam Steering Can Scale back the Price and Dimension of LiDAR Programs & Enhance Efficiency; Outcomes Reported at Photonics West 2021 March ninth, 2021


CEA-Leti Proclaims 16 Papers to Be Introduced At Photonics West 2021 and a Digital Workshop on March 25 March third, 2021


180 Diploma Capital Corp. to Report Fourth Quarter 2020 Monetary Outcomes on Monday, February 22, 2021 and to Host a Convention Name on Tuesday, February 23, 2021 February 19th, 2021

Nanobiotechnology


Arrowhead Prescription drugs to Webcast Fiscal 2021 Second Quarter Outcomes April 16th, 2021


French & Swiss Scientists Reveal ‘All-in-One’ Approach that May Speed up Phage-Remedy Prognosis: Lensless Imaging System Affirms Phage Remedy’s Worth in Treating Severe An infection, Tracks Phage Resistance and May Simply Be Applied in Compact Gadgets at Phage Lab April 13th, 2021


Power transmission by gold nanoparticles coupled to DNA buildings April ninth, 2021


A brand new agent for the mind ailments: mRNA April ninth, 2021

Supply

Leave a Comment